Patents Assigned to VALENTEK LLC
  • Derivatives of 7-fluoro-8-chloro-5H-dibenzo [B,E,] [1,4] diazepine and use thereof
    Patent number: 10391101
    Abstract: This present disclosure generally relates to medicine, and in particular to pharmacology and psychiatry, and discloses active agents and related methods of treatment which can be used for the treatment of treatment-resistant forms of schizophrenia. In some exemplary aspects, such treatments allow for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, without causing severe side effects that limit their use, such as sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: August 27, 2019
    Assignee: VALENTEK LLC
    Inventors: Maksim E. Zapolski, Margarita A. Morozova, Allan G. Beniashvili